Merck Wins FDA Lipfendra Approval, Exoplanet Atmosphere Boosts Habitability Hope, Lifestyle Changes Prevent Dementia, Macrophage Therapy Slows Aging, and more...
Published: July 20, 2026
Duration: 11:28
(0:10): FDA Approves Merck's Lipfendra, First Cholesterol-Lowering Pill, Offering Hope for High-Risk Patients
(2:03): Discovery of Atmosphere on Rocky Exoplanet LHS 1140 b Boosts Hope for Habitability
(4:19): WHO: Up to 45% of Dementia Cases Preventable with Lifestyle Changes
(6:39): Targeted Macrophage Therapy Slows Aging, Improves Health in Mice: A Step Toward Human Applications
(8:51): Aral Sea Drying Releases 748 Million Tons of CO2, Transforming Carbon Sink into Major Emissions Source
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: WSOC TV
(2:03): Discovery of Atmosphere on Rocky Exoplanet LHS 1140 b Boosts Hope for Habitability
(4:19): WHO: Up to 45% of Dementia Cases Preventable with Lifestyle Changes
(6:39): Targeted Macrophage Therapy Slows Aging, Improves Health in Mice: A Step Toward Human Applications
(8:51): Aral Sea Drying Releases 748 Million Tons of CO2, Transforming Carbon Sink into Major Emissions Source
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: WSOC TV